Cardiovascular outcomes of patients treated for non-Hodgkin lymphoma with first-line doxorubicin-based chemotherapy.

Humans Middle Aged Retrospective Studies Lymphoma, Non-Hodgkin / drug therapy Doxorubicin / therapeutic use Rituximab Lymphoma, Follicular / drug therapy Lymphoma, Large B-Cell, Diffuse / drug therapy Vincristine / therapeutic use Cyclophosphamide / therapeutic use Prednisone / therapeutic use Anthracyclines Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Cardiovascular toxicity DLBCL R-CHOP doxorubicin doxorubicin-induced cardiotoxicity immunochemotherapy lymphoma

Journal

Leukemia & lymphoma
ISSN: 1029-2403
Titre abrégé: Leuk Lymphoma
Pays: United States
ID NLM: 9007422

Informations de publication

Date de publication:
Dec 2022
Historique:
pubmed: 20 9 2022
medline: 26 1 2023
entrez: 19 9 2022
Statut: ppublish

Résumé

We conducted a single-center retrospective study to assess cardiovascular (CV) toxicity and treatment discontinuation for CV toxicity in diffuse large B-cell lymphoma (DLBCL) or follicular lymphoma (FL) patients treated with immunochemotherapy (R-CHOP-like). Between 2006 and 2017, 433 patients were included (DLBCL:

Identifiants

DOI: 10.1080/10428194.2022.2123222 PMID: 36120853
pubmed: 36120853
doi: 10.1080/10428194.2022.2123222
doi:

Substances chimiques

Doxorubicin 80168379AG
Rituximab 4F4X42SYQ6
Vincristine 5J49Q6B70F
Cyclophosphamide 8N3DW7272P
Prednisone VB0R961HZT
Anthracyclines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3340-3350

Auteurs

Alexandra Zduniak (A)

Department of Hematology, Centre Henri Becquerel, Rouen, France.

Emilie Lévêque (E)

Department of Statistics and Clinical Research Unit, Centre Henri Becquerel, Rouen, France.

Anne Perdrix (A)

Department of Biopathology, Rouen, France.
IRON Group, INSERM U1245, UNIROUEN, Rouen University Hospital, Normandy Centre for Genomic and Personalized Medicine, Normandie Université, Rouen, France.

Pascaline Etancelin (P)

Department of Hematology, Centre Henri Becquerel, Rouen, France.
Department of Biopathology, Rouen, France.
INSERM U1245, Université de Rouen, IRIB, Rouen, France.

Anne-Lise Ménard (AL)

Department of Hematology, Centre Henri Becquerel, Rouen, France.

Pascal Lenain (P)

Department of Hematology, Centre Henri Becquerel, Rouen, France.

Nathalie Contentin (N)

Department of Hematology, Centre Henri Becquerel, Rouen, France.

Louis-Ferdinand Pépin (LF)

Department of Statistics and Clinical Research Unit, Centre Henri Becquerel, Rouen, France.

Stéphane Leprêtre (S)

Department of Hematology, Centre Henri Becquerel, Rouen, France.

Emilie Lemasle (E)

Department of Hematology, Centre Henri Becquerel, Rouen, France.

Hélène Lanic (H)

Department of Hematology, Centre Henri Becquerel, Rouen, France.

Aspasia Stamatoullas-Bastard (A)

Department of Hematology, Centre Henri Becquerel, Rouen, France.

Leila Kammoun-Quique (L)

Department of Hematology-Oncology, Centre Hospitalier d'Evreux, Evreux, France.

Hervé Tilly (H)

Department of Hematology, Centre Henri Becquerel, Rouen, France.
INSERM U1245, Université de Rouen, IRIB, Rouen, France.

Fabrice Bauer (F)

Advanced Heart Failure, Department of Thoracic and cardiovascular Surgery, Charles Nicolle University Hospital, Rouen, France.

Fabrice Jardin (F)

Department of Hematology, Centre Henri Becquerel, Rouen, France.
INSERM U1245, Université de Rouen, IRIB, Rouen, France.

Vincent Camus (V)

Department of Hematology, Centre Henri Becquerel, Rouen, France.
INSERM U1245, Université de Rouen, IRIB, Rouen, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Cardiovascular outcomes of patients treated...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Cardiovascular outcomes of patients treated...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études rétrospectives › Cardiovascular outcomes of patients treated...
questionsmedicales.fr › Maladies du système immunitaire › Syndromes immunoprolifératifs › Syndromes lymphoprolifératifs › Lymphomes › Lymphome malin non hodgkinien › Cardiovascular outcomes of patients treated...
questionsmedicales.fr › Glucides › Hétérosides › Aminosides › Anthracyclines › Daunorubicine › Doxorubicine › Cardiovascular outcomes of patients treated...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Globulines › Sérum-globulines › Immunoglobulines › Anticorps › Anticorps monoclonaux › Anticorps monoclonaux d'origine murine › Rituximab › Cardiovascular outcomes of patients treated...
questionsmedicales.fr › Maladies du système immunitaire › Syndromes immunoprolifératifs › Syndromes lymphoprolifératifs › Lymphomes › Lymphome malin non hodgkinien › Lymphome folliculaire › Cardiovascular outcomes of patients treated...
questionsmedicales.fr › Maladies du système immunitaire › Syndromes immunoprolifératifs › Syndromes lymphoprolifératifs › Lymphomes › Lymphome malin non hodgkinien › Lymphome B › Lymphome B diffus à grandes cellules › Cardiovascular outcomes of patients treated...
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › Indolizine › Indolizidines › Alcaloïdes indoliques › Alcaloïdes formés par condensation de sécologanine et de tryptamine › Alcaloïdes de Vinca › Vincristine › Cardiovascular outcomes of patients treated...
questionsmedicales.fr › Composés chimiques organiques › Composés organiques du phosphore › Phosphoramides › Moutardes phosphoramide › Cyclophosphamide › Cardiovascular outcomes of patients treated...
questionsmedicales.fr › Composés polycycliques › Composés à cycles fusionnés › Stéroïdes › Prégnanes › Prégnadiènes › Prégnadiènediols › Prednisone › Cardiovascular outcomes of patients treated...
questionsmedicales.fr › Glucides › Hétérosides › Aminosides › Anthracyclines › Cardiovascular outcomes of patients treated...
questionsmedicales.fr › Thérapeutique › Traitement médicamenteux › Association de médicaments › Protocoles de polychimiothérapie antinéoplasique › Cardiovascular outcomes of patients treated...